{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T00:09:18Z","timestamp":1795133358253,"version":"4.10.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T00:00:00Z","timestamp":1634342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T00:00:00Z","timestamp":1634342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007903","name":"Bloodwise","doi-asserted-by":"publisher","award":["15036"],"award-info":[{"award-number":["15036"]}],"id":[{"id":"10.13039\/501100007903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007903","name":"Bloodwise","doi-asserted-by":"publisher","award":["15036"],"award-info":[{"award-number":["15036"]}],"id":[{"id":"10.13039\/501100007903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["A21019"],"award-info":[{"award-number":["A21019"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["A9609"],"award-info":[{"award-number":["A9609"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["A21019"],"award-info":[{"award-number":["A21019"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chromosomal abnormalities are established prognostic markers in adult ALL. We assessed the prognostic impact of established chromosomal abnormalities and key copy number alterations (CNA) among 652 patients with B-cell precursor ALL treated on a modern MRD driven protocol. Patients with <jats:italic>KMT2A-AFF1<\/jats:italic>, complex karyotype (CK) and low hypodiploidy\/near-triploidy (HoTr) had high relapse rates 50%, 60% &amp; 53% and correspondingly poor survival. Patients with <jats:italic>BCR-ABL1<\/jats:italic> had an outcome similar to other patients. JAK-STAT abnormalities (<jats:italic>CRLF2<\/jats:italic>, <jats:italic>JAK2<\/jats:italic>) occurred in 6% patients and were associated with a high relapse rate (56%). Patients with ABL-class fusions were rare (1%). A small group of patients with <jats:italic>ZNF384<\/jats:italic> fusions (<jats:italic>n<\/jats:italic>\u2009=\u200912) had very good survival. CNA affecting <jats:italic>IKZF1, CDKN2A\/B, PAX5, BTG1, ETV6, EBF1, RB1<\/jats:italic> and PAR1 were assessed in 436 patients. None of the individual deletions or profiles were associated with survival, either in the cohort overall or within key subgroups. Collectively these data indicate that primary genetic abnormalities are stronger prognostic markers than secondary deletions. We propose a revised UKALL genetic risk classification based on key established chromosomal abnormalities: (1) very high risk: CK, HoTr or JAK-STAT abnormalities; (2) high risk: <jats:italic>KMT2A<\/jats:italic> fusions; (3) Tyrosine kinase activating: <jats:italic>BCR-ABL1<\/jats:italic> and ABL-class fusions; (4) standard risk: all other patients.<\/jats:p>","DOI":"10.1038\/s41375-021-01448-2","type":"journal-article","created":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T20:27:13Z","timestamp":1634416033000},"page":"625-636","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study"],"prefix":"10.1038","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9781-6107","authenticated-orcid":false,"given":"Anthony V.","family":"Moorman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Barretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellie R.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor J.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Twentyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy A.","family":"Kirkwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Enshaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8536-5428","authenticated-orcid":false,"given":"Tom","family":"Creasey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3486-3168","authenticated-orcid":false,"given":"Daniel","family":"Leongamornlert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1709-8983","authenticated-orcid":false,"given":"Elli","family":"Papaemmanuil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pip","family":"Patrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Clifton-Hadley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1875-8974","authenticated-orcid":false,"given":"Bela","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Menne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew K.","family":"McMillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine J.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare J.","family":"Rowntree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David I.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4746-7789","authenticated-orcid":false,"given":"Adele K.","family":"Fielding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,16]]},"reference":[{"key":"1448_CR1","doi-asserted-by":"crossref","unstructured":"Bassan R, Bourquin JP, DeAngelo DJ, Chiaretti S. New approaches to the management of adult acute lymphoblastic leukemia. J Clin Oncol. 2018: JCO2017773648.","DOI":"10.1200\/JCO.2017.77.3648"},{"key":"1448_CR2","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1182\/blood-2006-10-051912","volume":"109","author":"AV Moorman","year":"2007","unstructured":"Moorman AV, Harrison CJ, Buck GA, Richards SM, Secker-Walker LM, Martineau M, et al. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII\/Eastern Cooperative Oncology Group (ECOG) 2993 Trial. Blood. 2007;109:3189\u201397.","journal-title":"Blood"},{"key":"1448_CR3","doi-asserted-by":"publisher","first-page":"4489","DOI":"10.1182\/blood-2009-01-199380","volume":"113","author":"AK Fielding","year":"2009","unstructured":"Fielding AK, Rowe JM, Richards SM, Buck G, Moorman AV, Durrant IJ, et al. Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII\/ECOG2993. Blood. 2009;113:4489\u201396. May 07.","journal-title":"Blood"},{"key":"1448_CR4","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3324\/haematol.2012.081877","volume":"98","author":"DI Marks","year":"2013","unstructured":"Marks DI, Moorman AV, Chilton L, Paietta E, Enshaie A, DeWald G, et al. The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)\/MLL-AFF1 prospectively treated in the UKALLXII\/ECOG2993 trial. Haematologica. 2013;98:945\u201352. Jun.","journal-title":"Haematologica"},{"key":"1448_CR5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/j.1365-2141.2009.07941.x","volume":"148","author":"B Patel","year":"2010","unstructured":"Patel B, Rai L, Buck G, Richards SM, Mortuza Y, Mitchell W, et al. Minimal residual disease is a significant predictor of treatment failure in non T-lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII\/ECOG2993. Br J Haematol. 2010;148:80\u20139. Jan.","journal-title":"Br J Haematol"},{"key":"1448_CR6","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1182\/blood-2007-10-116582","volume":"111","author":"AH Goldstone","year":"2008","unstructured":"Goldstone AH, Richards SM, Lazarus HM, Tallman MS, Buck G, Fielding AK, et al. In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation\/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII\/ECOG E2993). Blood. 2008;111:1827\u201333. Feb 15.","journal-title":"Blood"},{"key":"1448_CR7","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/leu.2016.219","volume":"31","author":"B Patel","year":"2017","unstructured":"Patel B, Kirkwood AA, Dey A, Marks DI, McMillan AK, Menne TF, et al. Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trial. Leukemia. 2017;31:58\u201364.","journal-title":"Leukemia"},{"key":"1448_CR8","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1200\/JCO.2011.40.3907","volume":"30","author":"AV Moorman","year":"2012","unstructured":"Moorman AV, Schwab C, Ensor HM, Russell LJ, Morrison H, Jones L, et al. IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemia. J Clin Oncol. 2012;30:3100\u20138.","journal-title":"J Clin Oncol"},{"key":"1448_CR9","doi-asserted-by":"publisher","first-page":"3809","DOI":"10.1002\/cncr.29579","volume":"121","author":"J Ribera","year":"2015","unstructured":"Ribera J, Morgades M, Zamora L, Montesinos P, Gomez-Segui I, Pratcorona M, et al. Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols. Cancer. 2015;121:3809\u201317.","journal-title":"Cancer"},{"key":"1448_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3324\/haematol.2014.112912","volume":"100","author":"S Safavi","year":"2015","unstructured":"Safavi S, Hansson M, Karlsson K, Biloglav A, Johansson B, Paulsson K. Novel gene targets detected by genomic profiling in a consecutive series of 126 adults with acute lymphoblastic leukemia. Haematologica. 2015;100:55\u201361.","journal-title":"Haematologica"},{"key":"1448_CR11","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1182\/blood-2014-01-547695","volume":"123","author":"K Beldjord","year":"2014","unstructured":"Beldjord K, Chevret S, Asnafi V, Huguet F, Boulland ML, Leguay T, et al. Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia. Blood. 2014;123:3739\u201349.","journal-title":"Blood"},{"key":"1448_CR12","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1182\/blood-2017-07-796862","volume":"131","author":"H Pfeifer","year":"2018","unstructured":"Pfeifer H, Raum K, Markovic S, Nowak V, Fey S, Oblander J, et al. Genomic CDKN2A\/2B deletions in adult Ph(+) ALL are adverse despite allogeneic stem cell transplantation. Blood. 2018;131:1464\u201375.","journal-title":"Blood"},{"key":"1448_CR13","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/bjh.14721","volume":"178","author":"M Messina","year":"2017","unstructured":"Messina M, Chiaretti S, Fedullo AL, Piciocchi A, Puzzolo MC, Lauretti A, et al. Clinical significance of recurrent copy number aberrations in B-lineage acute lymphoblastic leukaemia without recurrent fusion genes across age cohorts. Br J Haematol. 2017;178:583\u20137.","journal-title":"Br J Haematol"},{"key":"1448_CR14","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3324\/haematol.2018.196055","volume":"104","author":"AL Fedullo","year":"2019","unstructured":"Fedullo AL, Messina M, Elia L, Piciocchi A, Gianfelici V, Lauretti A, et al. Prognostic implications of additional genomic lesions in adult Philadelphia chromosome-positive acute lymphoblastic leukemia. Haematologica. 2019;104:312\u20138.","journal-title":"Haematologica"},{"key":"1448_CR15","doi-asserted-by":"publisher","first-page":"4352","DOI":"10.1200\/JCO.2009.22.0996","volume":"27","author":"MR Mansour","year":"2009","unstructured":"Mansour MR, Sulis ML, Duke V, Foroni L, Jenkinson S, Koo K, et al. Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia on the MRC UKALLXII\/ECOG E2993 protocol. J Clin Oncol. 2009;27:4352\u20136.","journal-title":"J Clin Oncol"},{"key":"1448_CR16","doi-asserted-by":"publisher","first-page":"4333","DOI":"10.1200\/JCO.2012.48.5292","volume":"31","author":"A Trinquand","year":"2013","unstructured":"Trinquand A, Tanguy-Schmidt A, Ben Abdelali R, Lambert J, Beldjord K, Lengline E, et al. Toward a NOTCH1\/FBXW7\/RAS\/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study. J Clin Oncol. 2013;31:4333\u201342.","journal-title":"J Clin Oncol"},{"key":"1448_CR17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1182\/blood-2017-04-778829","volume":"131","author":"A Petit","year":"2018","unstructured":"Petit A, Trinquand A, Chevret S, Ballerini P, Cayuela JM, Grardel N, et al. Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia. Blood. 2018;131:289\u2013300.","journal-title":"Blood"},{"key":"1448_CR18","doi-asserted-by":"crossref","unstructured":"Jenkinson S, Kirkwood AA, Goulden N, Vora A, Linch DC, Gale RE. Impact of PTEN abnormalities on outcome in pediatric patients with T-cell acute lymphoblastic leukemia treated on the MRC UKALL2003 trial. Leukemia. 2016;30:39\u201347.","DOI":"10.1038\/leu.2015.206"},{"key":"1448_CR19","first-page":"E11711","volume":"115","author":"JF Li","year":"2018","unstructured":"Li JF, Dai YT, Lilljebjorn H, Shen SH, Cui BW, Bai L, et al. Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases. Proc Natl Acad Sci USA. 2018;115:E11711\u2013E11720.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1448_CR20","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41588-018-0315-5","volume":"51","author":"Z Gu","year":"2019","unstructured":"Gu Z, Churchman ML, Roberts KG, Moore I, Zhou X, Nakitandwe J, et al. PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia. Nat Genet. 2019;51:296\u2013307.","journal-title":"Nat Genet"},{"key":"1448_CR21","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1182\/blood-2017-05-742643","volume":"130","author":"H Lilljebjorn","year":"2017","unstructured":"Lilljebjorn H, Fioretos T. New oncogenic subtypes in pediatric B-cell precursor acute lymphoblastic leukemia. Blood. 2017;130:1395\u2013401.","journal-title":"Blood"},{"key":"1448_CR22","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1200\/JCO.2016.69.0073","volume":"35","author":"KG Roberts","year":"2017","unstructured":"Roberts KG, Gu Z, Payne-Turner D, McCastlain K, Harvey RC, Chen IM, et al. High frequency and poor outcome of Philadelphia chromosome-like acute lymphoblastic leukemia in adults. J Clin Oncol. 2017;35:394\u2013401.","journal-title":"J Clin Oncol"},{"key":"1448_CR23","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1182\/blood-2016-07-726588","volume":"129","author":"N Jain","year":"2017","unstructured":"Jain N, Roberts KG, Jabbour E, Patel K, Eterovic AK, Chen K, et al. Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults. Blood. 2017;129:572\u201381.","journal-title":"Blood"},{"key":"1448_CR24","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/leu.2016.375","volume":"31","author":"SK Tasian","year":"2017","unstructured":"Tasian SK, Hurtz C, Wertheim GB, Bailey NG, Lim MS, Harvey RC, et al. High incidence of Philadelphia chromosome-like acute lymphoblastic leukemia in older adults with B-ALL. Leukemia. 2017;31:981\u20134.","journal-title":"Leukemia"},{"key":"1448_CR25","doi-asserted-by":"crossref","unstructured":"Chiaretti S, Messina M, Della Starza I, Piciocchi A, Cafforio L, Cavalli M, et al. Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913. Haematologica. 2021;106:1559\u201368.","DOI":"10.3324\/haematol.2020.247973"},{"key":"1448_CR26","doi-asserted-by":"crossref","unstructured":"Paietta E, Roberts KG, Wang V, Gu Z, Buck G, Pei D, et al. Molecular Classification Improves Risk Assessment in Adult BCR-ABL1-negative B-ALL. Blood. 2021;138:948\u201358.","DOI":"10.1182\/blood.2020010144"},{"key":"1448_CR27","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1182\/blood.2019001244","volume":"134","author":"I Tanasi","year":"2019","unstructured":"Tanasi I, Ba I, Sirvent N, Braun T, Cuccuini W, Ballerini P, et al. Efficacy of tyrosine kinase inhibitors in Ph-like acute lymphoblastic leukemia harboring ABL-class rearrangements. Blood. 2019;134:1351\u20135.","journal-title":"Blood"},{"key":"1448_CR28","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.3324\/haematol.2019.231720","volume":"105","author":"G Cario","year":"2020","unstructured":"Cario G, Leoni V, Conter V, Attarbaschi A, Zaliova M, Sramkova L, et al. Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols. Haematologica. 2020;105:1887\u201394.","journal-title":"Haematologica"},{"key":"1448_CR29","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/bjh.17093","volume":"191","author":"AV Moorman","year":"2020","unstructured":"Moorman AV, Schwab C, Winterman E, Hancock J, Castleton A, Cummins M, et al. Adjuvant tyrosine kinase inhibitor therapy improves outcome for children and adolescents with acute lymphoblastic leukaemia who have an ABL-class fusion. Br J Haematol. 2020;191:844\u201351.","journal-title":"Br J Haematol"},{"key":"1448_CR30","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/gcc.22956","volume":"60","author":"T Creasey","year":"2021","unstructured":"Creasey T, Enshaei A, Nebral K, Schwab C, Watts K, Cuthbert G, et al. Single nucleotide polymorphism array-based signature of low hypodiploidy in acute lymphoblastic leukemia. Genes Chromosomes Cancer. 2021;60:604\u201315.","journal-title":"Genes Chromosomes Cancer"},{"key":"1448_CR31","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/leu.2009.268","volume":"24","author":"M Bruggemann","year":"2010","unstructured":"Bruggemann M, Schrauder A, Raff T, Pfeifer H, Dworzak M, Ottmann OG, et al. Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008. Leukemia. 2010;24:521\u201335.","journal-title":"Leukemia"},{"key":"1448_CR32","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1182\/blood-2003-04-1299","volume":"104","author":"C Charrin","year":"2004","unstructured":"Charrin C, Thomas X, Ffrench M, Le QH, Andrieux J, Mozziconacci MJ, et al. A report from the LALA-94 and LALA-SA groups on hypodiploidy with 30 to 39 chromosomes and near-triploidy: 2 possible expressions of a sole entity conferring poor prognosis in adult acute lymphoblastic leukemia (ALL). Blood. 2004;104:2444\u201351.","journal-title":"Blood"},{"key":"1448_CR33","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/gcc.20133","volume":"42","author":"K Paulsson","year":"2005","unstructured":"Paulsson K, Horvat A, Fioretos T, Mitelman F, Johansson B. Formation of der(19)t(1;19)(q23;p13) in acute lymphoblastic leukemia. Genes Chromosomes Cancer. 2005;42:144\u20138.","journal-title":"Genes Chromosomes Cancer"},{"key":"1448_CR34","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1200\/JCO.2017.74.3617","volume":"36","author":"M Stanulla","year":"2018","unstructured":"Stanulla M, Dagdan E, Zaliova M, Moricke A, Palmi C, Cazzaniga G, et al. IKZF1(plus) defines a new minimal residual disease-dependent very-poor prognostic profile in pediatric b-cell precursor acute lymphoblastic leukemia. J Clin Oncol. 2018;36:1240\u20139.","journal-title":"J Clin Oncol"},{"key":"1448_CR35","doi-asserted-by":"crossref","unstructured":"Mitchell RJ, Kirkwood AA, Barretta E, Clifton-Hadley L, Lawrie E, Lee S, et al. IKZF1 alterations are not associated with outcome in 498 adults with B-precursor ALL enrolled on the UKALL14 trial. Blood Adv. 2021;5:3322\u201332.","DOI":"10.1182\/bloodadvances.2021004430"},{"key":"1448_CR36","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1182\/bloodadvances.2018025718","volume":"3","author":"L Hamadeh","year":"2019","unstructured":"Hamadeh L, Enshaei A, Schwab C, Alonso CN, Attarbaschi A, Barbany G, et al. Validation of the United Kingdom copy-number alteration classifier in 3239 children with B-cell precursor ALL. Blood Adv. 2019;3:148\u201357.","journal-title":"Blood Adv"},{"key":"1448_CR37","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1182\/blood-2014-03-562918","volume":"124","author":"AV Moorman","year":"2014","unstructured":"Moorman AV, Enshaei A, Schwab C, Wade R, Chilton L, Elliott A, et al. A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia. Blood. 2014;124:1434\u201344.","journal-title":"Blood"},{"key":"1448_CR38","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/ng.2532","volume":"45","author":"L Holmfeldt","year":"2013","unstructured":"Holmfeldt L, Wei L, Diaz-Flores E, Walsh M, Zhang J, Ding L, et al. The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nat Genet. 2013;45:242\u201352.","journal-title":"Nat Genet"},{"key":"1448_CR39","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1200\/JCO.18.00822","volume":"37","author":"CH Pui","year":"2019","unstructured":"Pui CH, Rebora P, Schrappe M, Attarbaschi A, Baruchel A, Basso G, et al. Outcome of children with hypodiploid acute lymphoblastic leukemia: a retrospective multinational study. J Clin Oncol. 2019;37:770\u20139.","journal-title":"J Clin Oncol"},{"key":"1448_CR40","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1182\/blood-2017-05-783852","volume":"130","author":"M Lafage-Pochitaloff","year":"2017","unstructured":"Lafage-Pochitaloff M, Baranger L, Hunault M, Cuccuini W, Lefebvre C, Bidet A, et al. Impact of cytogenetic abnormalities in adults with Ph-negative B-cell precursor acute lymphoblastic leukemia. Blood. 2017;130:1832\u201344.","journal-title":"Blood"},{"key":"1448_CR41","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1182\/blood-2013-09-529008","volume":"123","author":"AK Fielding","year":"2014","unstructured":"Fielding AK, Rowe JM, Buck G, Foroni L, Gerrard G, Litzow MR, et al. UKALLXII\/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia. Blood. 2014;123:843\u201350.","journal-title":"Blood"},{"key":"1448_CR42","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1182\/blood.V87.8.3135.bloodjournal8783135","volume":"87","author":"GFCH.","year":"1996","unstructured":"GFCH. Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings and outcome. A Collaborative Study of the Groupe Francais de Cytogenetique Hematologique. Blood. 1996;87:3135\u201342.","journal-title":"Blood"},{"key":"1448_CR43","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1182\/blood-2004-07-2922","volume":"105","author":"M Mancini","year":"2005","unstructured":"Mancini M, Scappaticci D, Cimino G, Nanni M, Derme V, Elia L, et al. A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol. Blood. 2005;105:3434\u201341.","journal-title":"Blood"},{"key":"1448_CR44","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1182\/blood-2018-99-115716","volume":"132","author":"T Yasuda","year":"2018","unstructured":"Yasuda T, Nishijima D, Kojima S, Kawazu M, Ueno T, Tsuzuki S, et al. Genomic and clinical characterization of adult Ph-negative B-cell acute lymphoblastic leukemia. Blood. 2018;132:2821.","journal-title":"Blood"},{"key":"1448_CR45","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1182\/blood-2011-04-347872","volume":"119","author":"GM Dores","year":"2012","unstructured":"Dores GM, Devesa SS, Curtis RE, Linet MS, Morton LM. Acute leukemia incidence and patient survival among children and adults in the United States, 2001\u20132007. Blood. 2012;119:34\u201343.","journal-title":"Blood"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-021-01448-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-021-01448-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-021-01448-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T13:07:41Z","timestamp":1650632861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-021-01448-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,16]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["1448"],"URL":"https:\/\/doi.org\/10.1038\/s41375-021-01448-2","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,16]]},"assertion":[{"value":"18 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}